Innoviva, Inc. (NASDAQ: INVA) (“Innoviva” or the “Company”), a diversified holding company with a core royalties portfolio, a ...
The US federal government has named the next 15 medicines that will be subject to Medicare pricing negotiation and reductions due to come into effect at the start of 2028. The list has been announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results